BeiGene, Ltd.
Stock Forecast, Prediction & Price Target
BeiGene, Ltd. (BGNE) stock Price Target by analysts
$247.5
Potential upside: 33.99%
BeiGene, Ltd. price prediction
What is BeiGene, Ltd. stock analysts` prediction?
BeiGene, Ltd. stock forecast: Based on 2 Wall Street analysts` predicted price targets for BeiGene, Ltd. in the last 3 months, the avarage price target is $247.5, with a high forecast of $NaN. The average price target represents a 33.99% change from the last price of $184.71.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
BeiGene, Ltd. stock Price Target by analysts
Full breakdown of analysts given BeiGene, Ltd. price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Rebecca Liang Bernstein | 50% 1/2 | 9 months ago | $207 12.06% upside | $207.83 | StreetInsider | Previous targets (1) |
Reni Benjamin JMP Securities | 0% 0/1 | 12 months ago | $288 55.92% upside | $197.51 | StreetInsider | Previous targets (0) |
Matthew Harrison Morgan Stanley | 0% 0/1 | about 1 year ago | $307 66.20% upside | $193.57 | StreetInsider | Previous targets (0) |
Kelly Shi Jefferies | 0% 0/1 | over 1 year ago | $283 53.21% upside | $164.44 | StreetInsider | Previous targets (0) |
Rebecca Liang Bernstein | 50% 1/2 | about 2 years ago | $196 6.11% upside | $178.46 | Benzinga | Previous targets (1) |
Michael Schmidt Guggenheim | 100% 1/1 | almost 3 years ago | $205 10.98% upside | $151.3 | TheFly | Previous targets (0) |
BeiGene, Ltd. Financial Estimates
BeiGene, Ltd. Revenue Estimates
BeiGene, Ltd. EBITDA Estimates
BeiGene, Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.17B N/A | $1.41B 20.37% | $2.45B 73.65% | Avg: $4.02B Low: $3.82B High: $4.22B avg. 63.58% | Avg: $5.03B Low: $4.71B High: $5.38B avg. 25.09% | Avg: $6.30B Low: $5.90B High: $6.75B avg. 25.32% | Avg: $6.97B Low: $6.53B High: $7.47B avg. 10.62% |
Net Income
% change YoY
| $-1.41B N/A | $-2.00B -41.77% | $-881.70M 55.99% | Avg: $-345.62M Low: $-914.43M High: $-33.40M avg. 60.80% | Avg: $222.79M Low: $-383.10M High: $529.24M avg. 164.46% | Avg: $830.47M Low: $762.20M High: $907.00M avg. 272.75% | Avg: $1.30B Low: $1.19B High: $1.42B avg. 57.10% |
EBITDA
% change YoY
| $-1.43B N/A | $-1.78B -24.40% | $-1.12B 37.13% | Avg: $-3.58B Low: $-3.76B High: $-3.40B avg. -218.71% | Avg: $-4.48B Low: $-4.80B High: $-4.20B avg. -25.09% | Avg: $-5.61B Low: $-6.01B High: $-5.26B avg. -25.32% | Avg: $-6.21B Low: $-6.65B High: $-5.82B avg. -10.62% |
EPS
% change YoY
| -$15.23 N/A | -$19.43 -27.57% | -$8.45 56.51% | Avg: -$3.62 Low: -$8.76 High: -$0.32 avg. 57.11% | Avg: $1.83 Low: -$3.67 High: $5.07 avg. 150.47% | Avg: $7.96 Low: $7.3 High: $8.69 avg. 334.89% | Avg: $12.5 Low: $11.47 High: $13.65 avg. 57.10% |
Operating Expenses
% change YoY
| $990.87M N/A | $1.27B 29.03% | $3.28B 157.04% | Avg: $4.18B Low: $3.98B High: $4.39B avg. 27.42% | Avg: $5.23B Low: $4.90B High: $5.61B avg. 25.09% | Avg: $6.56B Low: $6.15B High: $7.03B avg. 25.32% | Avg: $7.26B Low: $6.80B High: $7.77B avg. 10.62% |
FAQ
What is BeiGene, Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 138.77% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is -914.43M, average is -345.62M and high is -33.40M.
What is BeiGene, Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 31.15% in 2025-2028.
We have gathered data from 16 analysts. Their low revenue estimate is $3.82B, average is $4.02B and high is $4.22B.
What is BeiGene, Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 149.89% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is -$8.76, average is -$3.62 and high is $-0.32.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering BeiGene, Ltd. stock. The most successful analyst is Rebecca Liang whose win rate is 50%. He has correctly predicted 1/2 price targets.